BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical

Segment
Start Up





 Company News
Ligand Pharmaceuticals Inc. (LGND) Partner SAGE Therapeutics Receives Fast Track Designation For Captisol-enabled SAGE-547 To Treat Status Epilepticus 7/23/2014 12:24:03 PM
SAGE Therapeutics Announces Closing Of Initial Public Offering 7/23/2014 12:16:23 PM
SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus 7/22/2014 6:49:33 AM
SAGE Therapeutics Announces Full Exercise Of Over-Allotment Option 7/21/2014 4:04:07 PM
SAGE Therapeutics Announces Pricing Of Initial Public Offering 7/18/2014 10:58:40 AM
Cambridge's SAGE Therapeutics Ups Proposed IPO Deal Size 7/17/2014 8:46:21 AM
Cambridge-Based SAGE Therapeutics Readies $69 Million IPO Pitch To Develop CNS Drugs 6/18/2014 6:59:12 AM
SAGE Therapeutics Appoints James M. Frates To The Company’s Board Of Directors 6/10/2014 6:48:07 AM
SAGE Therapeutics Presents Preliminary SAGE-547 Clinical Data At Epilepsy Pipeline Conference 6/5/2014 10:00:28 AM
Ligand Pharmaceuticals Inc. (LGND) Earns Milestone From SAGE Therapeutics For SAGE-547 5/12/2014 8:57:34 AM
123